Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sinzinger

Showing results (241-250 of 672) with videos related to

Pageof 68
Sort By:
Wiener Klinische Wochenschrift|June 21, 1985
[Deficiencies of the prostaglandin system: III. A partial thromboxane synthetase defect]H Sinzinger, S Reiter, B A Peskar
Transplantation Proceedings|August 1, 1987
Platelet-derived growth factor and prostacyclin in kidney transplant rejectionH Sinzinger, T Zidek, M L Foegh
Prostaglandins, Leukotrienes, and Medicine|November 1, 1986
Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-lifeE Strobl-Jäger, K Widhalm, H Sinzinger
Journal of Receptor and Signal Transduction Research|March 11, 1999
Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cellsG Sobal, H Sinzinger, E J Menzel
Acta Histochemica|January 1, 1985
[A semiquantitative method of determining alkaline phosphatase activity in human arterial wall]E Strobl-Jäger, W Firbas, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|March 1, 1984
Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic comaP Polterauer, H Sinzinger, B A Peskar
Wiener Klinische Wochenschrift|February 3, 1984
[Radioisotope labeling of human blood cells--a historic overview]M L Thakur, H Sinzinger, R Höfer
Journal of Cardiovascular Pharmacology|October 13, 2005
Troglitazone inhibits long-term glycation and oxidation of low-density lipoproteinGrazyna Sobal, E J Menzel, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 6, 2000
The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidationG Sobal, E J Menzel, H Sinzinger
Pageof 68

Showing results (241-250 of 672) with videos related to

Sort By:
Pageof 68
Wiener Klinische Wochenschrift|June 21, 1985
[Deficiencies of the prostaglandin system: III. A partial thromboxane synthetase defect]H Sinzinger, S Reiter, B A Peskar
Transplantation Proceedings|August 1, 1987
Platelet-derived growth factor and prostacyclin in kidney transplant rejectionH Sinzinger, T Zidek, M L Foegh
Prostaglandins, Leukotrienes, and Medicine|November 1, 1986
Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-lifeE Strobl-Jäger, K Widhalm, H Sinzinger
Journal of Receptor and Signal Transduction Research|March 11, 1999
Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cellsG Sobal, H Sinzinger, E J Menzel
Acta Histochemica|January 1, 1985
[A semiquantitative method of determining alkaline phosphatase activity in human arterial wall]E Strobl-Jäger, W Firbas, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|March 1, 1984
Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic comaP Polterauer, H Sinzinger, B A Peskar
Wiener Klinische Wochenschrift|February 3, 1984
[Radioisotope labeling of human blood cells--a historic overview]M L Thakur, H Sinzinger, R Höfer
Journal of Cardiovascular Pharmacology|October 13, 2005
Troglitazone inhibits long-term glycation and oxidation of low-density lipoproteinGrazyna Sobal, E J Menzel, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 6, 2000
The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidationG Sobal, E J Menzel, H Sinzinger
Pageof 68